Exchange transfusion and intravenous immunoglobulin use in the UK

Phototherapy and exchange blood transfusion are primary treatment modes for significant haemolytic disease of the newborn (HDN), to lower serum bilirubin and reduce risk of kernicterus. 1 Incidence of HDN has decreased in recent years and there has been concern over decreased experience in performin...

Full description

Saved in:
Bibliographic Details
Published inArchives of disease in childhood. Fetal and neonatal edition Vol. 95; no. 1; pp. F76 - F77
Main Authors Ng, G Y T, Roberts, I, New, H V
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health 01.01.2010
BMJ Publishing Group LTD
Subjects
Blood transfusions
Erythroblastosis, Fetal - therapy
Exchange Transfusion, Whole Blood - utilization
Health Care Surveys
Humans
Immunoglobulins
Immunoglobulins, Intravenous - therapeutic use
Infant, Newborn
Light therapy
Surveys and Questionnaires
United Kingdom
United Kingdom > UK
Online AccessGet full text

Cover

More Information
Summary:Phototherapy and exchange blood transfusion are primary treatment modes for significant haemolytic disease of the newborn (HDN), to lower serum bilirubin and reduce risk of kernicterus. 1 Incidence of HDN has decreased in recent years and there has been concern over decreased experience in performing exchange transfusions. 2 The American Academy of Pediatrics recommends intravenous immunoglobulin (IVIG) use for newborns with HDN due to Rh and ABO incompatibility and rising bilirubin. 3 IVIG may be an alternative to exchange transfusion to avoid some exchange transfusion-related complications.
Bibliography:href:fetalneonatal-95-F76.pdf
ark:/67375/NVC-BFVZFPDG-3
ArticleID:fn162123
istex:1EBF2FFB16EAFC709844B72C4CBC88F6277E3B92
local:fetalneonatal;95/1/F76
SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:1359-2998
1468-2052
DOI:10.1136/adc.2009.162123